OVERVIEW

Cancer Summaries and Commentaries™: Report from Orlando on Advances in the Treatment of hronic lymphocytic leukemia (CLL) is organized by Physicians' Education Resource, LLC (PER).

Release Date: December 24, 2019
Expiration Date: December 24, 2020

Accreditation:
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Activity Overview:
This online activity is designed to update physicians on data presented at the American Society of Hematology Annual Meeting, held in December 2019 in Orlando, Florida. The Cancer Summaries and Commentaries™: Report from Orlando on Advances in the Treatment of CLL online continuing medical education (CME) activity facilitates critical assessment and clinical integration of new evidence, when appropriate. The activity reviews 6 abstracts with the most recent and clinically pertinent chronic lymphocytic leukemia (CLL) presentations from the meeting. For each abstract, a short summary introduction, study design, key clinical data, and a conclusion is accompanied by expert perspectives that provide insight into how clinicians can apply these findings to their clinical practice to improve patient care.

Learning Objectives:
Upon successful completion of this educational activity, you should be better prepared to:
• Outline novel treatment options exploring targeted therapies, immunotherapies, and combination therapies in patients with CLL
• Explain the study design, rationale, and results of recent clinical trials evaluating novel strategies for the treatment of CLL
• Consider best practices to apply novel treatment strategies for the treatment of patients with CLL